News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
43,692 Results
Type
Article (4092)
Company Profile (22)
Press Release (39577)
Section
Business (11215)
Career Advice (36)
Deals (1496)
Drug Delivery (6)
Drug Development (5706)
Employer Resources (6)
FDA (677)
Job Trends (1046)
News (18880)
Policy (1430)
Tag
Academia (374)
Accelerated approval (1)
Allergies (2)
Alliances (4517)
ALS (10)
Alzheimer's disease (40)
Antibody-drug conjugate (ADC) (24)
Approvals (678)
Artificial intelligence (40)
Autoimmune disease (2)
Automation (5)
Bankruptcy (12)
Best Places to Work (947)
BIOSECURE Act (1)
Biotechnology (13)
Bladder cancer (12)
Brain cancer (10)
Breast cancer (49)
Cancer (503)
Cardiovascular disease (8)
Career advice (34)
CAR-T (17)
Cell therapy (51)
Cervical cancer (1)
Clinical research (4372)
Collaboration (135)
Compensation (24)
COVID-19 (186)
CRISPR (24)
C-suite (30)
Cystic fibrosis (22)
Data (359)
Depression (1)
Diabetes (9)
Diagnostics (1515)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (17)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (3555)
Employer branding (2)
Employer resources (6)
Events (6242)
Executive appointments (48)
FDA (780)
Frontotemporal dementia (1)
Funding (76)
Gene editing (59)
Gene therapy (64)
GLP-1 (22)
Government (168)
Guidances (15)
Healthcare (865)
HIV (15)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (6)
Immuno-oncology (1)
Indications (1)
Infectious disease (202)
Inflammatory bowel disease (6)
Influenza (4)
Intellectual property (10)
Interviews (2)
IPO (659)
Job creations (132)
Job search strategy (31)
Layoffs (17)
Legal (248)
Liver cancer (11)
Longevity (4)
Lung cancer (54)
Lymphoma (36)
Machine learning (3)
Management (1)
Manufacturing (44)
MASH (2)
Medical device (317)
Medtech (317)
Mergers & acquisitions (894)
Metabolic disorders (16)
Multiple sclerosis (5)
Neurodegenerative disease (5)
Neuroscience (76)
NextGen: Class of 2025 (320)
Non-profit (204)
Now hiring (2)
Obesity (8)
Opinion (15)
Ovarian cancer (27)
Pain (1)
Pancreatic cancer (22)
Parkinson's disease (8)
Partnered (2)
Patents (18)
Patient recruitment (12)
Peanut (2)
People (2818)
Pharmaceutical (5)
Phase I (1768)
Phase II (2075)
Phase III (1224)
Pipeline (181)
Policy (4)
Postmarket research (115)
Preclinical (950)
Press Release (30)
Prostate cancer (16)
Radiopharmaceuticals (19)
Rare diseases (56)
Real estate (270)
Recruiting (3)
Regulatory (1155)
Reports (5)
Research institute (351)
Resumes & cover letters (6)
RNA editing (2)
RSV (2)
Schizophrenia (2)
Series A (12)
Series B (9)
Service/supplier (2)
Sickle cell disease (13)
Special edition (1)
Spinal muscular atrophy (9)
Sponsored (3)
Startups (290)
Stomach cancer (1)
Supply chain (5)
Vaccines (49)
Venture capital (3)
Weight loss (2)
Women's health (2)
Date
Today (3)
Last 7 days (29)
Last 30 days (102)
Last 365 days (2288)
2025 (1526)
2024 (2737)
2023 (3036)
2022 (4094)
2021 (3792)
2020 (3296)
2019 (2667)
2018 (2073)
2017 (2161)
2016 (2182)
2015 (2422)
2014 (1635)
2013 (1415)
2012 (1423)
2011 (1480)
2010 (1377)
Location
Africa (50)
Alabama (4)
Alaska (1)
Arizona (12)
Arkansas (1)
Asia (2088)
Australia (439)
California (753)
Canada (177)
China (55)
Colorado (25)
Connecticut (14)
Delaware (9)
Europe (6469)
Florida (60)
Georgia (1)
Idaho (2)
Illinois (62)
India (3)
Indiana (13)
Iowa (6)
Japan (15)
Kansas (3)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (74)
Massachusetts (422)
Michigan (11)
Minnesota (4)
Missouri (6)
Nebraska (2)
Nevada (5)
New Hampshire (2)
New Jersey (156)
New York (201)
North Carolina (95)
North Dakota (8)
Northern California (377)
Ohio (17)
Oregon (1)
Pennsylvania (119)
Rhode Island (2)
South America (58)
South Carolina (3)
Southern California (274)
Tennessee (6)
Texas (165)
United States (2280)
Utah (54)
Virginia (4)
Washington D.C. (2)
Washington State (29)
Wisconsin (18)
43,692 Results for "codex dna".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
Codexis, Inc. announced it has entered into an agreement with Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, whereby Aldevron will acquire a global exclusive license to Codexis’ Codex® HiCap RNA Polymerase.
December 13, 2023
·
6 min read
Biotech Beach
Codex DNA Expands Application of Proprietary Error Correction Technology
Codex DNA, Inc. announced commercial release of BioXp® Error-corrected Libraries kits that enable researchers to automate synthesis of DNA variant libraries on the award-winning BioXp® automated synthetic biology workstation.
October 4, 2022
·
3 min read
Press Releases
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
August 15, 2025
·
14 min read
Press Releases
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
July 1, 2025
·
6 min read
Press Releases
Mitochondrial DNA Market to Reach USD 687.99 Million by 2034
July 31, 2025
·
1 min read
Biotech Beach
Codex DNA Announces Plan to Change Corporate Name to Telesis BioNovel name reflects expansion of capabilities and solutions
Codex DNA, Inc. today announced a plan to change its Company name to Telesis Bio.
October 12, 2022
·
2 min read
Business
Codex DNA Reports Second Quarter 2022 Financial Results
Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the second quarter ended June 30, 2022.
August 9, 2022
·
7 min read
Press Releases
DNA Polymerase Market Size Forecasts USD 420 Million in 2025
July 24, 2025
·
1 min read
Press Releases
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
August 26, 2025
·
3 min read
Biotech Beach
Codex DNA Debuts Next-Generation Automated Synthetic Biology WorkstationBioXp™ 9600 system
Codex DNA, Inc. today announced commercial release and first shipment of the BioXp™ 9600 system, a next-generation high throughput platform designed to revolutionize synthetic biology workflows.
September 19, 2022
·
3 min read
1 of 4,370
Next
